Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | GRO-a | 6515.0 | 62 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | GRO-a | 231.5 | 52 | |
N2645 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | GRO-a | 1105.0 | 40 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | GRO-a | 2534.0 | 51 | |
RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | GRO-a | 10094.0 | 52 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | GRO-a | 10825.0 | 51 | |
RA2159 | TNF-a | 100 | ng/mL | 4 | GRO-a | 11371.0 | 42 | ||||
N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | GRO-a | 4959.0 | 41 | |
N2645 | TNF-a | 100 | ng/mL | 4 | GRO-a | 5580.0 | 43 | ||||
RA2708 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | GRO-a | 14183.0 | 43 | |
RA2708 | TNF-a | 100 | ng/mL | 4 | GRO-a | 14819.0 | 48 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 4 | GRO-a | 229.0 | 46 | ||||
RA2159 | IKK16 | 2.0 | uM | 4 | GRO-a | 315.5 | 28 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 4 | GRO-a | 41.5 | 34 | ||||
N2645 | IKK16 | 2.0 | uM | 4 | GRO-a | 48.5 | 50 | ||||
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 4 | GRO-a | 1654.5 | 46 | ||||
RA2708 | IKK16 | 2.0 | uM | 4 | GRO-a | 1904.0 | 55 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 4 | GRO-a | 351.0 | 58 | ||||
RA2159 | 4 | GRO-a | 420.5 | 46 | |||||||
N2645 | Tofacitinib | 0.3 | uM | 4 | GRO-a | 84.5 | 34 | ||||
N2645 | 4 | GRO-a | 74.0 | 29 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 4 | GRO-a | 2506.0 | 31 | ||||
RA2708 | 4 | GRO-a | 1628.0 | 33 | |||||||
RA2159 | 4 | GRO-a | 334.5 | 36 | |||||||
N2645 | 4 | GRO-a | 84.5 | 54 |